Advances in Brain Stimulation for Depression
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background: Major depressive disorder is a common and debilitating psychiatric disorder that negatively impacts a large portion of the population. Although a range of antidepressant treatments have been developed, many patients are unable to obtain an adequate therapeutic response despite completing several antidepressant medication trials. As a result, neurostimulation treatment modalities have been developed as potential alternatives. This article provides an overview of advances in neurostimulation for treating depression. Methods: We conducted a comprehensive review of the neurostimulation literature to identify recent findings involving the description and rationale, efficacy, and side effects of vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), and deep brain stimulation (DBS). Results: VNS and TMS are the newest neurostimulation modalities that have been approved by the FDA for treating depression. VNS is approved for patients with treatment-resistant depression (TRD), while TMS has demonstrated efficacy only for milder forms of TRD. Despite demonstrated efficacy, further research is needed to address certain limitations and/or determine how best to utilize these forms of neurostimulation. Investigational forms of neurostimulation include MST and DBS. Although MST and DBS have demonstrated promise as a depression treatment, research is still being conducted to determine and/or enhance their antidepressant properties. Conclusions: Although electroconvulsive therapy remains the primary and most effective treatment option for patients with severe TRD, there have been considerable gains in the field of neurostimulation. Many of the neurostimulation techniques described in this review represent promising treatment alternatives for patients with TRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcranial direct current stimulation: State of the art 2008
Nitsche, M. A., Cohen, L. G., Wassermann, E. M., Priori, A., Lang, N., Antal, A., Paulus, W., Hummel, F., Boggio, P. S., Fregni, F., et al. (2008) · Brain Stimulation · doi:10.1016/j.brs.2008.06.004 · Cited by 3,057
O’Reardon, J. P., Solvason, H. B., Janicak, P. G., Sampson, S., Isenberg, K. E., Nahas, Z., McDonald, W. M., Avery, D., Fitzgerald, P. B., Loo, C., et al. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.018 · Cited by 1,910
Cost of Lost Productive Work Time Among US Workers With Depression
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.289.23.3135 · Cited by 1,421
George, M. S., Lisanby, S. H., Avery, D., McDonald, W. M., Durkalski, V., Pavlicova, M., Anderson, B., Nahas, Z., Bulow, P., Zarkowski, P., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.46 · Cited by 1,092 · cited 1×
“44,45 These side effects can be reduced by increasing the intensity and decreasing the frequency of rTMS delivery.”
Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression
George, M. S., Wassermann, E. M., Williams, W. A., Callahan, A., Ketter, T. A., Basser, P., Hallett, M., & Post, R. M. (1995) · NeuroReport · doi:10.1097/00001756-199510020-00008 · Cited by 954
Sackeim, H. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00271-8 · Cited by 568
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years
Kennedy, S. H., Giacobbe, P., Rizvi, S. J., Placenza, F. M., Nishikawa, Y., Mayberg, H. S., & Lozano, A. M. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10081187 · Cited by 481 · cited 1×
“61”
Nierenberg, A. A., Husain, M. M., Trivedi, M. H., Fava, M., Warden, D., Wisniewski, S. R., Miyahara, S., & Rush, A. J. (2010) · Psychological Medicine · doi:10.1017/s0033291709006011 · Cited by 458
Self-citationBerlim, M. T., & Turecki, G. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200108 · Cited by 412
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs
Crown, W. H., Finkelstein, S., Berndt, E. R., Ling, D., Poret, A. W., Rush, A. J., & Russell, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1102 · Cited by 386
George, M. S., Rush, A. J., Marangell, L. B., Sackeim, H. A., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Moreno, F., Rittberg, B., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.028 · Cited by 372
Berlim, M. T., & Turecki, G. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.009 · Cited by 249
Transcranial magnetic brain stimulation: Therapeutic promises and scientific gaps
Wassermann, E. M., & Zimmermann, T. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.003 · Cited by 243 · cited 2×
“36 However, as its potential for changing synaptic connectivity and activity became apparent, interest in TMS began to shift toward its potential clinical application.”
Stefurak, T., Mikulis, D., Mayberg, H., Lang, A. E., Hevenor, S., Pahapill, P., Saint‐Cyr, J., & Lozano, A. (2003) · Movement Disorders · doi:10.1002/mds.10593 · Cited by 215 · cited 1×
“58-60 Although promising results regarding the antidepressant properties of DBS have been reported, the invasive and investigational nature of DBS limits current trials to patients with severe TRD. 58 Efficacy of DBS for depression.”
Kayser, S., Bewernick, B. H., Grubert, C., Hadrysiewicz, B. L., Axmacher, N., & Schlaepfer, T. E. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.09.008 · Cited by 194 · cited 2×
“52,54,55 Achieving a faster reorientation time with MST is a significant finding, given that time to reorientation has been identified as a predictor of long-term cognitive side effects.”
InfluentialEconomic implications of treatment-resistant depression among employees
Greenberg, P., Corey-Lisle, P. K., Birnbaum, H., Marynchenko, M., & Claxton, A. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422060-00003 · Cited by 113
Anesthetic Considerations for Magnetic Seizure Therapy: A Novel Therapy for Severe Depression
White, P. F., Amos, Q., Zhang, Y., Stool, L., Husain, M. M., Thornton, L., Downing, M., McClintock, S., & Lisanby, S. H. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000221182.71648.a3 · Cited by 111
Self-citationQuick recovery of orientation after magnetic seizure therapy for major depressive disorder
Kirov, G., Ebmeier, K. P., Scott, A. I. F., Atkins, M., Khalid, N., Carrick, L., Stanfield, A., O'Carroll, R. E., Husain, M. M., & Lisanby, S. H. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.044362 · Cited by 108 · cited 1×
“52,54,55 Achieving a faster reorientation time with MST is a significant finding, given that time to reorientation has been identified as a predictor of long-term cognitive side effects.”
Self-citation
Cited by
Zilverstand, A., Parvaz, M. A., & Goldstein, R. Z. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2016.06.009 · Cited by 360
Gut Vagal Afferents Differentially Modulate Innate Anxiety and Learned Fear
Klarer, M., Arnold, M., Günther, L., Winter, C., Langhans, W., & Meyer, U. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0252-14.2014 · Cited by 159
“The clinical relevance of dysfunctional vagal activity is further reflected by the recent use of chronic vagus nerve stimulation (VNS) for treatment-resistant affective diseases (George et al., 2008; Wani et al., 2013).”
BackgroundVagus nerve stimulation in psychiatry: a systematic review of the available evidence
Cimpianu, C.-L., Strube, W., Falkai, P., Palm, U., & Hasan, A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1642-2 · Cited by 138
Hasan, A., Wolff-Menzler, C., Pfeiffer, S., Falkai, P., Weidinger, E., Jobst, A., Hoell, I., Malchow, B., Yeganeh-Doost, P., Strube, W., et al. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-015-0618-9 · Cited by 80
“Invasive vagus nerve stimulation (VNS) has been established as an adjunctive treatment for medically refractory epilepsy [13] and is also approved for major depression [35, 52].”
BackgroundGarcia-Oscos, F., Peña, D., Housini, M., Cheng, D., Lopez, D., Borland, M. S., Salgado-Delgado, R., Salgado, H., D’Mello, S., Kilgard, M. P., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.07.020 · Cited by 43
Metadata
- Authors
- Wani, A., Trevino, K., Marnell, P., & Husain, M. M.
- Venue
- Annals of Clinical Psychiatry
- Publisher
- SAGE Publications
- Published
- 2013-08
- Volume
- 25
- Issue
- 3
- Pages
- 217-224
- ISSN
- 1040-1237 (ISSN-L)
- 1547-3325
- OpenAlex
- W184849867
- Cited by
- 42
- References
- 18
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.